Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use Recall 2026
OCTREOTIDE ACETATEIssued March 17, 2026Updated Reviewed by the Recall Watch editorial team
OCTREOTIDE ACETATE Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greec — recalled per FDA on 3/17/2026. Reason: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer..
- Agency
- FDA
- Issued
- Mar 17, 2026
- Brand
- OCTREOTIDE ACETATE
- Distribution
- 1 states
- Lots affected
- 11
Steps to take for this recall
Stop using it
Take it out of rotation. Don't consume, wear, or operate.
Verify the match
Compare lot numbers, UPCs, and dates against your product.
Return or dispose
Follow the manufacturer's instructions to refund or safely dispose.
Free case review
Were you or someone in your household prescribed this medication?
- Free
- No obligation
- Licensed attorneys
Attorney advertising.DetailsHide
Recall Watch is not a law firm and does not provide legal or medical advice. Free case reviews are provided by independent licensed attorneys; Recall Watch may receive a referral fee. Prior results do not guarantee a similar outcome. Submitting this form does not create an attorney-client relationship. See our terms and privacy policy.
What's recalled
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9259-08.

Restock your medicine cabinet
First-aid kits, thermometers and OTC basics, searched on Amazon.
Need it delivered? Start a free Amazon Prime trial.
Why it was recalled
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Affected products & lot numbers11 lots called out
Affected Lot Numbers
Check your product label — do not use if your lot number appears below.
| Lot Number |
|---|
| Lot: 4401491 |
| 4401600 |
| 4401603 |
| 4401629 |
| Exp.: 9/31/2026 |
| 4500594 |
| 4500786 |
| 4500920 |
| 4501007 |
| 4501462 |
| Exp.: 3/31/2027. |
Where was it sold1 state
Nationwide in the USA
More recalls like this7 related — by brand, contaminant, and category
Other OCTREOTIDE ACETATE recalls
Recent Medications recalls
- Wedgewood Pharmacy Certain Compounded Veterinary Medications Within Expiry Recall 20262026
- Par Health Issues Voluntary Nationwide Argatroban Injection Recall 20262026
- Par Pharmaceutical Par Health Issues Voluntary Nationwide Two Lots Recall 20262026
Frequently asked questions
Is the OCTREOTIDE ACETATE recall still active?
Yes, this recall is currently active as of March 17, 2026. Do not use or consume the affected product.
What lot numbers are affected?
Affected lot numbers: Lot: 4401491, 4401600, 4401603, 4401629, Exp.: 9/31/2026, 4500594, 4500786, 4500920, 4501007, 4501462, Exp.: 3/31/2027.. Check the label on your product.
What should I do if I have the recalled OCTREOTIDE ACETATE?
Do not consume or use this product. Return it to the store for a full refund, or dispose of it safely.